Hosted on MSN21d
Johnson & Johnson (JNJ) Q4 2024 Earnings Call TranscriptIn 2024, 6.2%, as I mentioned, and we're pleased with ... our Tecnis premium IOLs, Acuvue Oasys Max and contact lens, Velys portfolio in ortho, our Stratafix portfolio in barbed sutures, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback